New Search

Your search (  ) found 115 results.

Books and Monographs
1 Artificial Paradises : A Drugs Reader.
Jay, Mike ; (editor/s)
London: Penguin Books, 1999.

ADAI BOOK Call No: PN 56 N18 A69 1999

[more]
2 Addiction : From Biology to Drug Policy / 2nd ed.
Goldstein, Avram
Oxford : Oxford University Press, 2001.

ADAI BOOK Call No: RC 564 G66 2001

[more]
3
National Drug Threat Assessment 2006. (NDIC Product No. 2006-Q0317-001)
National Drug Intelligence Center ; Walther, Michael F.
Johnstown, PA: National Drug Intelligence Center, January 2006.

ADAI BOOK Call No: HV 5830 N44 2006

[more]
4
National Drug Threat Assessment 2004. (NDIC Product No. 2004-Q037-002)
National Drug Intelligence Center ; Horn, Michael T
Johnstown, PA: National Drug Intelligence Center, April 2004.

ADAI BOOK Call No: HV 5830 N44 2004

[more]
5
National Drug Threat Assessment, 2003. (NDIC Product No. 2003-Q0317-001)
National Drug Intelligence Center ; Horn, Michael T
Johnstown, PA : National Drug Intelligence Center, U.S. Department of Justice, January 2003.

ADAI BOOK Call No: HV 5830 N44 2003

[more]
6 National Drug Threat Assessment 2002. (NDIC Product No. 2002-Q0317-001)
National Drug Intelligence Center ; Horn, Michael T
Johnstown, PA : National Drug Intelligence Center, December 2001.

ADAI BOOK Call No: HV 5830 N44 2002

[more]
7
Psychedelic Drugs Reconsidered.
Grinspoon, Lester ; Bakalar, James B
New York : The Lindesmith Center, [1979], 1997.

ADAI BOOK Call No: BF 209 H34 G74 1997

[more]


Articles, Chapters, and Reprints
8 Hallucinogens.
Suzuki J ; Halpern JH ; Passie T ; Huertas PE
IN: Cohen LM ; Collins FL Jr ; Young AM ; McHargue DE ; Leffingwell TR ; Cook KL (eds). PHARMACOLOGY AND TREATMENT OF SUBSTANCE ABUSE: EVIDENCE- AND OUTCOME-BASED PERSPECTIVES. New York : Routledge, 2009, pp. 393-417     (Chapter) [Call No: RC 564 P484 2009 [REF HAND]]     [ ]
9 Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use.
Wu LT ; Ringwalt CL ; Weiss RD ; Blazer DG
Drug Alcohol Depend 2009;104(1-2):156-66     (Journal)     [ PubMed abstract ]
UW Link
10 Salvia divinorum: The sage of the seers.
Furek MW
Counselor 2009;10(3):50-51     (Journal)     [ ]
11 Anorexia on acid.
Anonymous
Drugs Alcohol Today 2009;9(1):27-29     (Journal)     [ ]
12 Behavioral management: De-escalating PCP-intoxicated clients in acute settings.
Rustin TA
Counselor 2008;9(6):54-59     (Journal)     [ ]
13 Hallucinogen use disorders among adult users of MDMA and other hallucinogens.
Wu LT ; Ringwalt CL ; Mannelli P ; Patkar AA
Am J Addict 2008;17(5):354-63     (Journal)     [ PubMed abstract ]
ADAI/UW Link
14 Salvia divinorum use among a college student sample.
Khey DN ; Miller BL ; Griffin OH
J Drug Educ 2008;38(3):297-306     (Journal)     [ PubMed abstract ]
UW Link
15 The use of fry (embalming fluid and PCP-laced cigarettes or marijuana sticks) among crack cocaine smokers.
Peters RJ Jr ; Williams M ; Ross MW ; Atkinson J ; McCurdy SA
J Drug Educ 2008;38(3):285-95     (Journal)     [ PubMed abstract ]
UW Link
16 Chloroquine psychosis masquerading as PCP: a case report.
Collins GB ; McAllister MS
J Psychoactive Drugs 2008;40(2):211-4     (Journal)     [ PubMed abstract ]
UW Link
17 Legally high? Legal considerations of Salvia divinorum.
Griffin OH ; Miller BL ; Khey DN
J Psychoactive Drugs 2008;40(2):183-91     (Journal)     [ PubMed abstract ]
UW Link
18 Internet access to Salvia divinorum: implications for policy, prevention, and treatment.
Hoover V ; Marlowe DB ; Patapis NS ; Festinger DS ; Forman RF
J Subst Abuse Treat 2008;35(1):22-7     (Journal)     [ PubMed abstract ]
UW Link
19 "Research chemicals": tryptamine and phenethylamine use among high-risk youth.
Sanders B ; Lankenau SE ; Bloom JJ ; Hathazi D
Subst Use Misuse 2008;43(3-4):389-402     (Journal)     [ PubMed abstract ]
ADAI/UW Link
20 Between prohibitions: patterns and meanings of magic mushroom use in the UK.
Riley SC ; Blackman G
Subst Use Misuse 2008;43(1):55-71     (Journal)     [ PubMed abstract ]
ADAI/UW Link
21 Drugs on the internet. I: Introduction and web sites on psychedelic drugs.
Montagne M
Subst Use Misuse 2008;43(1):17-25     (Journal)     [ PubMed abstract ]
ADAI/UW Link
22 Use of specific hallucinogens: 2006.
SAMHSA Office of Applied Studies
NSDUH Report, Feb. 14, 2008, 4p.     (Online resource)     [ ]
Free Link
23 College student use of Salvia divinorum.
Lange JE ; Reed MB ; Croff JM ; Clapp JD
Drug Alcohol Depend 2008;94(1-3):263-6     (Journal)     [ PubMed abstract ]
UW Link
24 The creativity of Crumb: research on the effects of psychedelic drugs on the comic art of Robert Crumb.
Jones MT
J Psychoactive Drugs 2007;39(3):283-91     (Journal)     [ PubMed abstract ]
UW Link
25 Patterns of hallucinogen use and initiation: 2004 and 2005.
SAMHSA Office of Applied Studies
NSDUH Report, July 5, 2007, 4 p.     (Online resource)     [ ]
Free Link
26 Subjective effects of Salvia divinorum.
Dalgarno P
J Psychoactive Drugs 2007;39(2):143-9     (Journal)     [ PubMed abstract ]
UW Link
27 Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids.
Gillespie NA ; Neale MC ; Prescott CA ; Aggen SH ; Kendler KS
Addiction 2007;102(6):920-30.     (Journal)     [ PubMed abstract ]
UW Link
28 Adolescent salvia substance abuse.
Singh S
Addiction 2007;102(5):823-4     (Journal)     [ PubMed abstract ]
UW Link
29 Who is becoming hallucinogen dependent soon after hallucinogen use starts?
Stone AL ; O'brien MS ; De La Torre A ; Anthony JC
Drug Alcohol Depend 2007;87(2-3):153-63     (Journal)     [ NIHMS20572 | PubMed abstract ]
UW Link
30 Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids.
Gable RS
Addiction 2007;102(1):24-34     (Journal)     [ PubMed abstract ]
UW Link
31 5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users.
McCambridge J ; Winstock A ; Hunt N ; Mitcheson L
Eur Addict Res 2007;13(1):57-64     (Journal)     [ PubMed abstract ]
ADAI/UW Link
32 Evidence for a hallucinogen dependence syndrome developing soon after onset of hallucinogen use during adolescence.
Stone AL ; Storr CL ; Anthony JC
Int J Methods Psychiatr Res 2006;15(3):116-130     (Reprint 09673)     [ PubMed abstract ]
33 Designer drugs as a cause of homicide.
Matsumoto T ; Okada T
Addiction 2006;101(11):1666-7.     (Journal)     [ PubMed abstract ]
UW Link
34 An evaluation of phencyclidine (PCP) psychosis: a retrospective analysis at a state facility.
Carls KA ; Ruehter VL
Am J Drug Alcohol Abuse 2006;32(4):673-8     (Journal)     [ PubMed abstract ]
ADAI/UW Link
35 Pattern of use and subjective effects of Salvia divinorum among recreational users.
Gonzalez D ; Riba J ; Bouso JC ; Gomez-Jarabo G ; Barbanoj MJ
Drug Alcohol Depend 2006;85(2):157-62     (Journal)     [ PubMed abstract ]
UW Link
36 Illicit peyote use among American Indian adolescents in substance abuse treatment: a preliminary investigation.
Fickenscher A ; Novins DK ; Manson SM
Subst Use Misuse 2006;41(8):1139-54     (Journal)     [ PubMed abstract ]
ADAI/UW Link
37 Values and beliefs of psychedelic drug users: a cross-cultural study.
Lerner M ; Lyvers M
J Psychoactive Drugs 2006;38(2):143-7     (Journal)     [ PubMed abstract ]
UW Link
38 LSD before Leary : Sidney Cohen's critique of 1950s psychedelic drug research.
Novak SJ
IN: Tracy SW ; Acker CJ (eds). ALTERING AMERICAN CONSCIOUSNESS : THE HISTORY OF ALCOHOL AND DRUG USE IN THE UNITED STATES, 1800-2000. Boston : University of Massachusetts Press, 2004, pp.353-382     (Chapter) [Call No: HV 5292 A393 2004]     [ ]
39 Personality characteristics of adolescents with hallucinogen, methamphetamine, and cannabis dependence : A comparative study.
Palmer GA ; Daiss DD
J Child Adolesc Subst Abuse 2005;15(1):37-49     (Journal)     [ ]
ADAI/UW Link
40 Marijuana, hallucinogens, and club drugs.
McDowell D
IN: Frances RJ ; Miller SI ; Mack AH (eds.). CLINICAL TEXTBOOK OF ADDICTIVE DISORDERS / 3rd ed. New York : The Guilford Press, 2005, pp.157-183     (Chapter) [Call No: RC 564 C55 2005]     [ ]
41 Psychedelic sacraments.
Baker JR
J Psychoactive Drugs 2005;37(2):179-87     (Journal)     [ PubMed abstract ]
UW Link
42 Assessment of club drug, hallucinogen, inhalant, and steroid use and misuse.
Kilmer JR ; Palmer RS ; Cronce JM
IN: Donovan DM ; Marlatt GA (eds.). ASSESSMENT OF ADDICTIVE BEHAVIORS, SECOND EDITION. New York : The Guilford Press, 2005, pp.274-304     (Chapter) [Call No: RC 564 A98 2005]     [ ]
43 Relapse prevention for abuse of club drugs, hallucinogens, inhalants, and steroids.
Kilmer JR ; Cronce JM ; Palmer RS
IN: Marlatt GA ; Donovan DM (eds.). RELAPSE PREVENTION : MAINTENANCE STRATEGIES IN THE TREATMENT OF ADDICTIVE BEHAVIORS / 2nd edition. New York : The Guilford Press, 2005, pp.208-247     (Chapter) [Call No: RC 564 R45 2005]     [ ]
44 Exposure opportunity as a mechanism linking youth marijuana use to hallucinogen use.
Wilcox HC ; Wagner FA ; Anthony JC
Drug Alcohol Depend 2002;66(2):127-35     (Journal)     [ PubMed abstract ]
UW Link
45 Beliefs and social norms about cigarettes or marijuana sticks laced with embalming fluid and phencyclidine (PCP): why youth use “fry”.
Peters RJ Jr ; Kelder SH ; Meshack A ; Yacoubian GS Jr ; McCrimmons D ; Ellis A
Subst Use Misuse 2005;40(4):563-71     (Journal)     [ PubMed abstract ]
ADAI/UW Link
46 Hallucinogens.
Pechnick RN ; Ungerleider JT
In: Lowinson JH; Ruiz P; Millman RB; Langrod JG (eds.) SUBSTANCE ABUSE: A COMPREHENSIVE TEXTBOOK / 4th ed. -- Philadelphia: Lippincott, Williams & Wilkins, 2004. pp. 313-323     (Chapter) [Call No: RC 564 S826 2004 [REF HAND]]     [ ]
47 Phencyclidine (PCP).
Zukin SR ; Sloboda Z ; Javitt DC
In: Lowinson JH; Ruiz P; Millman RB; Langrod JG (eds.) SUBSTANCE ABUSE: A COMPREHENSIVE TEXTBOOK / 4th ed. -- Philadelphia: Lippincott, Williams & Wilkins, 2004. pp. 324-336     (Chapter) [Call No: RC 564 S826 2004 [REF HAND]]     [ ]
48 Young people, dance and the sub-culture consumption of drugs.
Moore K ; Miles S
Addict Res Theory 2004;12(6):507-523     (Journal)     [ ]
ADAI/UW Link
49 Neurobiology of hallucinogens.
Glennon RA
In: Galanter M ; Kleber HD (eds.). THE AMERICAN PSYCHIATRIC PUBLISHING TEXTBOOK OF SUBSTANCE ABUSE TREATMENT / 3rd ed. Washington, D.C. : American Psychiatric Publishing, Inc., 2004, pp. 41-46     (Chapter) [Call No: RC 564 A526 2004 [REF HAND]]     [ ]
50 Hallucinogens.
Pechnick RN ; Ungerleider JT
In: Galanter M ; Kleber HD (eds.). THE AMERICAN PSYCHIATRIC PUBLISHING TEXTBOOK OF SUBSTANCE ABUSE TREATMENT / 3rd ed. Washington, D.C. : American Psychiatric Publishing, Inc., 2004, pp. 199-209     (Chapter) [Call No: RC 564 A526 2004 [REF HAND]]     [ ]
51 Phencyclidine and ketamine.
Schnoll SH ; Weaver MF
In: Galanter M ; Kleber HD (eds.). THE AMERICAN PSYCHIATRIC PUBLISHING TEXTBOOK OF SUBSTANCE ABUSE TREATMENT / 3rd ed. Washington, D.C. : American Psychiatric Publishing, Inc., 2004, pp. 211-215     (Chapter) [Call No: RC 564 A526 2004 [REF HAND]]     [ ]
52 Acute physiologic and chronic histologic changes in rats and mice exposed to the unique hallucinogen salvinorin A.
Mowry M ; Mosher M ; Briner W
J Psychoactive Drugs 2003;35(3):379-82     (Journal)     [ PubMed abstract ]
53 The pharmacology of serotonergic hallucinogens and "designer drugs".
Glennon RA
In: Graham AW ; Schultz TK ; Mayo-Smith MF ; Ries RK ; Wilford BB (eds.) PRINCIPLES OF ADDICTION MEDICINE / 3rd ed. Chevy Chase, MD : American Society of Addiction Medicine, Inc., 1998, pp.271-285     (Chapter) [Call No: RC 564 M455 2003 [REF HAND]]     [ ]
54 Lysergic acid diethylamide (LSD) and other classical psychedelics.
Galloway GP
In: Graham AW ; Schultz TK ; Mayo-Smith MF ; Ries RK ; Wilford BB (eds.) PRINCIPLES OF ADDICTION MEDICINE / 3rd ed. Chevy Chase, MD : American Society of Addiction Medicine, Inc., 1998, pp.286     (Chapter) [Call No: RC 564 M455 2003 [REF HAND]]     [ ]
55 Management of stimulant, hallucinogen, marijuana, phencyclidine, and club drug intoxication and withdrawal.
Wilkins JN ; Mellott KG ; Markvitsa R ; Gorelick DA
In: Graham AW ; Schultz TK ; Mayo-Smith MF ; Ries RK ; Wilford BB (eds.) PRINCIPLES OF ADDICTION MEDICINE / 3rd ed. Chevy Chase, MD : American Society of Addiction Medicine, Inc., 2003, pp.671-695     (Chapter) [Call No: RC 564 M455 2003 [REF HAND]]     [ ]
56 Tripping on tryptamines "Foxy" and AMT.
Nuckols CC
Counselor 2003;4(4):42-43     (Journal)     [ ]
57 Hallucinogen persisting perception disorder: what do we know after 50 years? [Review]
Halpern JH ; Pope HG Jr
Drug Alcohol Depend 2003;69(2):109-19     (Journal)     [ PubMed abstract ]
UW Link
58 Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins.
Kendler KS ; Jacobson KC ; Prescott CA ; Neale MC
Am J Psychiatry 2003;160(4):687-695     (Reprint 09107)     [ ]
UW Link
59 Illy users in Connecticut: two case reports. [re: marijuana and PCP]
Modesto-Lowe V
Subst Abuse 2002;23(4):255-7     (Journal)     [ PubMed abstract ]
ADAI/UW Link
60 Hallucinogens and redemption.
de Rios MD ; Grob CS ; Baker JR
J Psychoactive Drugs 2002;34(3):239-48.     (Journal)     [ PubMed abstract ]
61 The serotonergic system and mysticism: could LSD and the nondrug-induced mystical experience share common neural mechanisms?
Goodman N
J Psychoactive Drugs 2002;34(3):263-72.     (Journal)     [ PubMed abstract ]
62 "Mushroom madness" in the Papua New Guinea Highlands: a case of nicotine poisoning?
Thomas B.
J Psychoactive Drugs 2002;34(3):321-3.     (Journal)     [ PubMed abstract ]
63 Experience with the interpersonal psychedelics.
Naranjo C
In: Holland J (ed.). ECSTASY : THE COMPLETE GUIDE. Rochester, VT : Park Street Press, 2001, pp.208-221     (Chapter) [Call No: RM 666 M35 E37 2001]     [ ]
64 Pharmepena-Psychonautics: Human intranasal, sublingual and oral pharmacology of5-methoxy-N,N-dimethyl-tryptamine.
Ott J
J Psychoactive Drugs 2001;33(4):403-7     (Journal)     [ PubMed abstract ]
65 Socio-cultural and psychological aspects of contemporary LSD use in Germany.
Prepeliczay S
J Drug Issues 2002;32(2):431-458     (Journal)     [ ]
UW Link
66 Symposium XVIII : Hallucinogens and religion : historical to scientific perspectives.
Griffiths RR ; deWit H
In: Harris LS (ed.). PROBLEMS OF DRUG DEPENDENCE, 2001 : PROCEEDINGS OF THE 63RD ANNUAL SCIENTIFIC MEETING, THE COLLEGE ON PROBLEMS OF DRUG DEPENCENCE, INC. Bethesda, MD : National Institute on Drug Abuse, 2002, pp.116-123     (Chapter) [Call No: HV 5825 C617 2001]     [ ]
67 Is the U.S. experiencing an incipient epidemic of hallucinogen use?
Golub A ; Johnson BD ; Sifaneck SJ ; Chesluk B ; Parker H
Subst Use Misuse 2001;36(12):1699-729     (Journal)     [ PubMed abstract ]
ADAI/UW Link
68 A case study of space-time distortion during a total lunar eclipse following street use of LSD.
Dawson KA
J Psychoactive Drugs 2001;33(3):301-5     (Journal)     [ PubMed abstract ]
69 Pharmanopo-psychonautics: human intranasal, sublingual, intrarectal, pulmonary and oral pharmacology of bufotenine.
Ott J
J Psychoactive Drugs 2001;33(3):273-81     (Journal)     [ PubMed abstract ]
70 Psychometric assessment of the Hallucinogen Rating Scale.
Riba J ; Rodriguez-Fornells A ; Strassman RJ ; Barbanoj MJ
Drug Alcohol Depend 2001;62(3):215-23.     (Journal)     [ PubMed abstract ]
UW Link
71 Bufotenine: toward an understanding of possible psychoactive mechanisms. [review]
McBride MC
J Psychoactive Drugs 2000;32(3):321-31     (Journal)     [ PubMed abstract ]
72 Teotlaqualli: the psychoactive food of the Aztec gods.
Elferink JG
J Psychoactive Drugs 1999; 31(4): 435-40     (Journal)     [ PubMed abstract ]
73 The pharmacology of phencyclidine and the hallucinogens.
Carroll M ; Comer S
In: Graham AW ; Schultz TK (eds.) PRINCIPLES OF ADDICTION MEDICINE : SECOND EDITION. Chevy Chase, MD : American Society of Addiction Medicine, Inc., 1998, pps. 153-162     (Chapter) [Call No: RC 564 M455 1998 [REF HAND]]     [ ]
74 Apoptosis induction by phencyclidine in the brains of rats of different ages.
Milosevic J ; Veskov R ; Vasilev V ; Rakic L ; Ruzdijic S
Addict Biol 2000;5(2):157-165     (Journal)     [ ]
UW Link
75 Management of stimulant, hallucinogen, marijuana and phencyclidine intoxication and withdrawal.
Wilkins JN ; Conner BT ; Gorelick DA
In: Graham AW ; Schultz TK (eds.) PRINCIPLES OF ADDICTION MEDICINE : SECOND EDITION. Chevy Chase, MD : American Society of Addiction Medicine, Inc., 1998, pps. 465-485     (Chapter) [Call No: RC 564 M455 1998 [REF HAND]]     [ ]
76 Cannabis and hallucinogens [pharmacological and clinical aspects].
Stephens RS
In: McCrady BS ; Epstein EE (eds.). ADDICTIONS: A COMPREHENSIVE GUIDEBOOK. New York : Oxford University Press, 1999, pp. 121-140     (Chapter) [Call No: RC 564 M327 1999 [REF HAND]]     [ ]
77 Effects of acute and chronic administration of methamphetamine or phencyclidine on plasma adrenocorticotropin, corticosterone and progesterone in rat.
Shirayama Y ; Hashimoto K ; Shirayama M ; Watanabe K ; Ogawa T ; Higuchi T ; Minabe Y
Addict Biol 1999;4(3):345-350     (Journal)     [ ]
UW Link
78 Comparative epidemiology of initial drug opportunities and transitions to first use: marijuana, cocaine, hallucinogens and heroin.
Van Etten ML ; Anthony JC
Drug Alcohol Depend 1999;54(2):117-25     (Journal)     [ PubMed abstract ]
UW Link
79 Do hallucinogens cause residual neuropsychological toxicity?
Halpern JH ; Pope HG Jr
Drug Alcohol Depend 1999;53(3):247-56     (Journal)     [ PubMed abstract ]
UW Link
80 Treatment of alcoholism using psychedelic drugs: a review of the program of research.
Mangini M
J Psychoactive Drugs 1998;30(4):381-418     (Journal)     [ PubMed abstract ]
81 LSD use and flashbacks in alcoholic patients.
Batzer W ; Ditzler T ; Brown C
J Addict Dis 1999;18(2):57-63     (Journal)     [ PubMed abstract ]
ADAI/UW Link
82 Hallucinogens, serotonin and obsessive-compulsive disorder.
Delgado PL ; Moreno FA
J Psychoactive Drugs 1998;30(4):359-66     (Journal)     [ PubMed abstract ]
83 Hallucinogenic drugs and plants in psychotherapy and shamanism.
Metzner R
J Psychoactive Drugs 1998;30(4):333-41     (Journal)     [ PubMed abstract ]
84 Hallucinogens at the turn of the century: an introduction.
Grob CS ; Greer GR ; Mangini M
J Psychoactive Drugs 1998;30(4):315-9     (Journal)     [ PubMed abstract ]
85 Pharmahuasca : human pharmacology of oral DMT plus harmine.
Ott J
J Psychoactive Drugs 1999;31(2):171-177     (Journal)     [ PubMed abstract ]
86 Neurobiology of hallucinogens.
Glennon RA
In: Galanter M ; Kleber HD (eds.) TEXTBOOK OF SUBSTANCE ABUSE TREATMENT, SECOND EDITION. Washington, DC : American Psychiatric Press, Inc., 1999, pp. 33-37     (Chapter) [Call No: RC 564 A525 1999 [REF HAND]]     [ ]
87 Hallucinogens [treatment].
Ungerleider JT ; Pechnick RN
In: Galanter M ; Kleber HD (eds.) TEXTBOOK OF SUBSTANCE ABUSE TREATMENT, SECOND EDITION. Washington, DC : American Psychiatric Press, Inc., 1999, pp. 195-203     (Chapter) [Call No: RC 564 A525 1999 [REF HAND]]     [ ]
88 Phencyclidine [treatment].
Schnoll SH ; Weaver MF
In: Galanter M ; Kleber HD (eds.) TEXTBOOK OF SUBSTANCE ABUSE TREATMENT, SECOND EDITION. Washington, DC : American Psychiatric Press, Inc., 1999, pp. 205-214     (Chapter) [Call No: RC 564 A525 1999 [REF HAND]]     [ ]
89 Phencyclidine.
Giannini AJ
In: Tarter, RE ; Ammerman RT ; Ott PJ (eds.) HANDBOOK OF SUBSTANCE ABUSE : NEUROBEHAVIORAL PHARMACOLOGY. New York: Plenum Press, 1998:579-587     (Chapter) [Call No: RC 564.15 H36 1998]     [ ]
90 Pharmacology of hallucinogens.
Glennon RA
In: Tarter, RE ; Ammerman RT ; Ott PJ (eds.) HANDBOOK OF SUBSTANCE ABUSE : NEUROBEHAVIORAL PHARMACOLOGY. New York: Plenum Press, 1998:217-227     (Chapter) [Call No: RC 564.15 H36 1998]     [ ]
91 Behavioral pharmacology of hallucinogens.
Morrison NK
In: Tarter, RE ; Ammerman RT ; Ott PJ (eds.) HANDBOOK OF SUBSTANCE ABUSE : NEUROBEHAVIORAL PHARMACOLOGY. New York: Plenum Press, 1998:229-240     (Chapter) [Call No: RC 564.15 H36 1998]     [ ]
92 Investigation of hallucinogenic and related beta-carbolines.
Grella B ; Dukat M ; Young R ; Teitler M ; Herrick-Davis K ; Gauthier CB ; Glennon RA
Drug Alcohol Depend 1998;50(2):99-107     (Journal)     [ PubMed abstract ]
UW Link
93 Indoleamine and the phenethylamine hallucinogens: mechanisms of psychotomimetic action.
Marek GJ ; Aghajanian GK
Drug Alcohol Depend 1998;51(1-2):189-98     (Journal)     [ PubMed abstract ]
UW Link
94 Embalming fluid-soaked marijuana: new high or new guise for PCP?
Holland JA ; Nelson L ; Ravikumar PR ; Elwood WN
J Psychoactive Drugs 1998;30(2):215-9     (Journal)     [ PubMed abstract ]
95 Hallucinogens, phencyclidine, marijuana, inhalants.
Weiss CJ ; Millman RB
In: Frances RJ ; Miller SI (eds.) CLINICAL TEXTBOOK OF ADDICTIVE DISORDERS / 2nd ed. New York : Guilford Press, 1998, pp.202-232     (Chapter) [Call No: RC 564 C55 1998]     [ ]
96 Is the use of ecstasy and hallucinogens increasing?
Schuster P ; Lieb R ; Lamertz C ; Wittchen HU
Eur Addict Res 1998;4(1/2):75-82     (Journal)     [ PubMed abstract ]
ADAI/UW Link
97 Expression of brain-derived neurotrophic factor (BDNF) mRNA in rat retrosplenial cortex following administration of phencyclidine.
Hashimoto K ; Minabe Y ; Iyo M
Addict Biol 1998;3(1):79-83     (Journal)     [ ]
UW Link
98 Neurochemistry of drug abuse: Neurochemistry of psychedelic drugs.
Callaway JC ; McKenna DJ
In: Karch SB (ed.) DRUG ABUSE HANDBOOK. Boca Raton, FL : CRC Press, 1998, pp. 485-498     (Chapter) [Call No: RM 316 D76 1998 [REF HAND]]     [ ]
99 Ketamine psychedelic therapy (KPT): a review of the results of ten years of research.
Krupitsky EM ; Grinenko AY
J Psychoactive Drugs 1997;29(2):165-83     (Journal)     [ PubMed abstract ]
100 Pharmacological potency and biodisposition of phencyclidine via inhalation exposure in mice.
Meng Y ; Lichtman AH ; Bridgen DT ; Martin BR
Drug Alcohol Depend 1996;43(1-2):13-22     (Journal)     [ PubMed abstract ]
UW Link
101 Illicit use of ketamine in Scotland.
Dalgarno PJ ; Shewan D
J Psychoactive Drugs 1996;28(2):191-9     (Journal)     [ PubMed abstract ]
102 Age-specific patterns of hallucinogen use in the US population: an analysis using generalized additive models.
Chilcoat HD ; Schutz CG
Drug Alcohol Depend 1996;43(3):143-53     (Journal)     [ PubMed abstract ]
UW Link
103 Hallucinogens.
Pechnick RN ; Ungerleider JT
In: Lowinson JH ; Ruiz P ; Millman RB ; Langrod JG (eds.) SUBSTANCE ABUSE : A COMPREHENSIVE TEXTBOOK, THIRD EDITION. Philadelphia: Williams & Wilkins, 1997, p. 230-238     (Chapter) [Call No: RC 564 S826 1997 [REF HAND]]     [ ]
104 Phencyclidine (PCP).
Zukin SR ; Sloboda Z ; Javitt DC
In: Lowinson JH ; Ruiz P ; Millman RB ; Langrod JG (eds.) SUBSTANCE ABUSE : A COMPREHENSIVE TEXTBOOK, THIRD EDITION. Philadelphia: Williams & Wilkins, 1997, p. 238-246     (Chapter) [Call No: RC 564 S826 1997 [REF HAND]]     [ ]
105 Induction of heat shock protein (HSP)-70 in posterior cingulate and retrospenial cortex of rat brain by dizocilpine and phencyclidine : Lack of protective effects of alpha receptor ligands.
Hashimoto K ; Tomitaka S ; Narita N ; Minabe Y ; Iyo M ; Fukui S
Addict Biol 1996;1(1):61-70     (Journal)     [ ]
106 Bufo toads and bufotenine: fact and fiction surrounding an alleged psychedelic.
Lyttle T ; Goldstein D ; Gartz J
J Psychoactive Drugs 1996;28(3):267-90     (Journal)     [ PubMed abstract ]
107 Female PCP-using jail detainees: proneness to violence and gender differences.
Fishbein DH
Addict Behav 1996;21(2):155-72     (Journal)     [ PubMed abstract ]
UW Link
108 Enhanced N-methyl-D-aspartate (NMDA)-induced activity following morphine: sensitivity to sigma and PCP ligands.
Larson AA ; Yukhananov RY ; Kreeger JS
NIDA Res Monogr 1995;147:146-60     (Chapter) [Call No: RC 568 O58 D47 1995]     [ ]
Free Link
109 The use of hallucinogens in the treatment of addiction.
Halpern JH
Addict Res 1996;4(2):177-189     (Journal)     [ ]
ADAI/UW Link
110 Attentional and social functioning of preschool-age children exposed to PCP and cocaine in utero.
Beckwith L ; Crawford S ; Moore JA ; Howard J
In: Lewis M ; Bendersky M (eds.) MOTHERS, BABIES, AND COCAINE : THE ROLE OF TOXINS IN DEVELOPMENT. Hillsdale, New Jersey : Lawrence Erlbaum Associates, Publishers, 1995, pp. 287-303     (Chapter) [Call No: RG 580 D76 M68 1995]     [ ]
111 An analysis of risk reduction among organized groups that promote marijuana and psychedelic drugs.
Jenks SM
J Drug Issues 1995;25(3):629-644     (Journal)     [ ]
112 Hallucinogenic drugs in psychiatric research and treatment: Perspectives and prospects.
Strassman RJ
J Nerv Ment Dis 1995;183:127-138     (Reprint 06936)     [ ]
113 Pathophysiological mechanisms possibly involved in the development of alcohol hallucinosis [letter]
Soyka M
Addiction 1995;90(2):289-90     (Journal)     [ PubMed abstract ]
114 The archaic use of hallucinogens in Europe: an archaeology of altered states [editorial]
Rudgley R
Addiction 1995;90(2):163-4     (Journal)     [ PubMed abstract ]


Web Links
115 Multidisciplinary Association for Psychedelic Studies (MAPS)
Link: http://www.maps.org
Description: Sarasota, FL. Membership-based research and education association. Studies risks and benefits of therapeutic, spiritual, and creative uses of psychedelic drugs and marijuana.
Subjects: Hallucinogens | Marijuana
New Search